Publications by authors named "Egle Daniel"

Claim this Profile
E
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.
Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, Zsuzsanna Bago-Horvath, Christian F Singer, Daniel Egle

Breast· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial.
Christian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, Sabine Danzinger, Christine Brunner, Daniel Egle

Breast· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Contour Irregularities in Implant-Based Breast Reconstruction: Long-Term Aesthetic Outcomes After Direct-to-Implant Versus Tissue Expander Techniques.
Theresia Stigger, Selina Neurauter, Barbara Del Frari, Katharina Spechtler, Maria Emilia Casari, Daniel Egle

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial.
Sherene Loi, Roberto Salgado, Giuseppe Curigliano, Roberto Iván Romero Díaz, Suzette Delaloge, Daniel Egle

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer.
Justin M Balko, Luca Licata, Xiao Qian Wang, Matteo Dugo, Chiun-Sheng Huang, Daniel Egle

NPJ Breast Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2- breast cancer: insights and implications.
Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, Christine Beichler, Dominik Hlauschek, Daniel Egle

NPJ Breast Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Perspectives in the Management of Triple-Negative Breast Cancer.
Rupert Bartsch, Zsuzsanna Bago-Horvath, Daniel Egle, Simon P Gampenrieder, Birgit Grünberger

Breast Care (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic anti-SRP antibody positive immune-mediated necrotizing myopathy in a young female associated with lymphoma.
Johanna Heugenhauser, Franziska Di Pauli, Günther Stockhammer, Andreas Chott, Clemens Feistritzer, Daniel Egle

J Neuromuscul Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Michael Knauer, Daniel Egle, Stefanie Hayoz, Ákos Sávolt, Christoph Tausch

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Polygenic Scores into Multifactorial Breast Cancer Risk Assessment: Insights from the First Year of Clinical Implementation in Western Austria.
Lukas Forer, Gunda Schwaninger, Kathrin Taxer, Florian Schnitzer, Daniel Egle

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of differentiating sonographic features between fibroadenomas and malignant tumors of the breast mimicking fibroadenomas: 10-year experience in 421 histologically verified cases.
Michael Swoboda, Johannes Deeg, Daniel Egle, Valentin Ladenhauf, Malik Galijasevic

Ultraschall Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux, Daniel Egle

Breast Cancer Res Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Efficacy and Safety of Cryotherapy in Chemotherapy-Induced Peripheral Neuropathy Between Upper and Lower Extremities: Results from the Randomized CROPSI Study.
Miriam Emmelheinz, Christian Marth, Daniel Egle, Katharina Leitner, Carmen Albertini

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Christian Fridolin Singer, Stephan Wenzel Jahn, Dominik Hlauschek, Ulrike Maria Heber, Charlotte Mang-Manger, Daniel Egle

Cancer Commun (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, Georg Pfeiler, Richard Greil, Daniel Egle

Breast· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Axillary Dissection Using Surgical Marker Navigation after Neoadjuvant Systemic Treatment in Breast Cancer Patients: A Single-Center Experience.
Daniel Egle, Christine Brunner, Magdalena Ritter, Verena Wieser, Katharina Knoll

Breast Care (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Application of real-time MRI/US fusion using dynamic reference points for co-registration as an alternative to MRI guided biopsy in a patient with bilateral invasive breast cancer].
Michael Swoboda, Johannes Deeg, Birgit Amort, Daniel Egle, Leonhard Gruber

Rofo· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer.
Eva Valentina Klocker, Daniel Egle, Rupert Bartsch, Gabriel Rinnerthaler, Michael Gnant

Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial.
Sherene Loi, Roberto Salgado, Giuseppe Curigliano, Roberto Iván Romero Díaz, Suzette Delaloge, Daniel Egle

Nat Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study.
Christine Brunner, Marjan Arvandi, Christian Marth, Daniel Egle, Florentina Baumgart

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Gabriel Rinnerthaler, Daniel Egle, Rupert Bartsch, Clemens A Schmitt, Andreas Petzer

Nat Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Comparison of Subjective Symptoms and Neurophysiological Findings in the Assessment of Neuropathy in Cancer Patients.
Vera Elisabeth Adreana Kleinveld, Miriam Emmelheinz, Daniel Egle, Magdalena Ritter, Wolfgang N Löscher

Diagnostics (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.
Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer-A prospective, randomized trial.
Christine Brunner, Miriam Emmelheinz, Daniel Egle, Magdalena Ritter, Katharina Leitner

Breast· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shear-Wave Elastography Gradient Analysis of Newly Diagnosed Breast Tumours: A Critical Analysis.
Johannes Deeg, Michael Swoboda, Daniel Egle, Verena Wieser, Afschin Soleiman

Diagnostics (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis